Breast Cancer Market Research Reports

Your Breast Cancer Market guide including research reports, industry analysis, market forecasts, market share, size and other info. Covers, breast cancer drugs, therapies and more.
RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

$ 2000


SummaryThe breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly dive...

$ 6995


Breast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer in women worldwide, accounting for 16% of all female cancers, making the disease exceedingly prevalent. In the past, breast cancer occurred less in wo...

$ 4995


Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development...

$ 2500


Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.This report provides comprehensive information on the t...

$ 2000


Breast cancer, a malignant neoplasm, is the second most common cancer and the most common cancer in women worldwide, accounting for 16% of all female cancers, making the disease exceedingly prevalent. The number of women diagnosed with breast canc...

$ 4995


The NGS services market in Europe is expected to reach USD 1,152 million by 2020 from USD 444 million in 2015, at a CAGR of 21% from 2015 to 2020. The European NGS services market is segmented on the basis of technology, application, end user, dis...

$ 5650


GlobalData's Medical Devices sector report, "Breast Cancer - Pipeline Review, 2015" provides an overview of Breast Cancer diagnostic tests currently in pipeline stage.The report provides comprehensive information on the pipeli...

$ 4000


HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is expressed less in the tumor. According to the American Society of Clinical Oncology, most of the patients with breast cancer are known to have HER2-neg...

$ 2500


Global Markets Direct's, ?Metastatic Breast Cancer - Pipeline Review, H1 2015', provides an overview of the Metastatic Breast Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic d...

$ 2000


According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing ...

$ 5650


Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carc...

$ 3000


Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carc...

$ 3000


PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuse...

$ 10995


HER2-Negative Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current...

$ 4995


HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the curren...

$ 6995


HER2-Negative Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the curr...

$ 4995


HER2-Negative Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the curr...

$ 4995


HER2-Negative Breast Cancer - Current and Future Players Summary GlobalData has released its pharma report, “HER2-Negative Breast Cancer - Current and Future Players”. The report is a vital source of up-to-date information w...

$ 2995


Global Markets Direct's, ?Breast Cancer - Pipeline Review, H1 2015', provides an overview of the Breast Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Breast Cance...

$ 2500

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: